Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997269 · ClinicalTrials.gov registry record · NA
Benefit of CoQ-10 in Patients on Statins
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00997269 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 37 participants.
The verdict
NCT00997269, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This study will investigate whether a supplement called co-enzyme Q10 can help ease or eliminate some of the side effects that result from taking statin medications. These side effects include muscle pain, fatigue or muscle cramping.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Co-enzyme Q-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00997269
The ClinicalTrials.gov registry entry for NCT00997269 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00997269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00997269 about?
NCT00997269 is a clinical study titled "Benefit of CoQ-10 in Patients on Statins". This study will investigate whether a supplement called co-enzyme Q10 can help ease or eliminate some of the side effects that result from taking statin medications. These side effects include muscle pain, fatigue or muscle cramping.
What is the current status of trial NCT00997269?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2009-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00997269?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Co-enzyme Q-10 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00997269?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.